{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:18:30Z","timestamp":1790965110888,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015639","name":"Japan Cardiovascular Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015639","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23lk0201109"],"award-info":[{"award-number":["JP23lk0201109"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23lk0221171"],"award-info":[{"award-number":["JP23lk0221171"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jns.2025.123661","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T14:45:18Z","timestamp":1755614718000},"page":"123661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effect of renal function on dual antiplatelet therapy using cilostazol for stroke prevention: a CSPS.com trial post hoc analysis"],"prefix":"10.1016","volume":"477","author":[{"given":"Junpei","family":"Koge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Fukuda-Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Minematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenori","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2025.123661_bb0005","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1161\/STROKEAHA.120.029680","article-title":"Chronic kidney disease and cerebrovascular disease: consensus and guidance from a KDIGO controversies conference","volume":"52","author":"Kelly","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2025.123661_bb0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2018.07.033","article-title":"Renal dysfunction increases the risk of recurrent stroke in patients with acute ischemic stroke","volume":"277","author":"Wang","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jns.2025.123661_bb0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0049-3848(96)00145-4","article-title":"Hemostasis, platelet function and serotonin in acute and chronic renal failure","volume":"83","author":"Malyszko","year":"1996","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jns.2025.123661_bb0020","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2025.123661_bb0025","first-page":"Cd008834","article-title":"Antiplatelet agents for chronic kidney disease","author":"Palmer","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jns.2025.123661_bb0030","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1161\/STROKEAHA.116.014761","article-title":"Effect of estimated glomerular filtration rate decline on the efficacy and safety of clopidgrel with aspirin in minor stroke or transient ischemic attack: CHANCE substudy (Clopidgrel in high-risk patients with acute nondisabling cerebrovascular events)","volume":"47","author":"Zhou","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2025.123661_bb0035","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1474-4422(19)30148-6","article-title":"Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial","volume":"18","author":"Toyoda","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2025.123661_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095313","article-title":"Cilostazol renoprotective effect: modulation of PPAR-\u03b3, NGAL, KIM-1 and IL-18 underlies its novel effect in a model of ischemia-reperfusion","volume":"9","author":"Ragab","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jns.2025.123661_bb0045","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jns.2025.123661_bb0050","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jns.2025.123661_bb0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.ajkd.2010.02.344","article-title":"Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates","volume":"56","author":"Horio","year":"2010","journal-title":"Am. J. Kidney Dis."},{"issue":"2013","key":"10.1016\/j.jns.2025.123661_bb0060","first-page":"1","article-title":"Clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, KDIGO","year":"2012","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.jns.2025.123661_bb0065","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","author":"The GUSTO investigators","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2025.123661_bb0070","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1002\/sim.1815","article-title":"A new approach to modeling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials","volume":"23","author":"Royston","year":"2004","journal-title":"Stat. Med."},{"key":"10.1016\/j.jns.2025.123661_bb0075","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1161\/STROKEAHA.121.034378","article-title":"Dual antiplatelet therapy using cilostazol with aspirin or clopidogrel: subanalysis of the CSPS.com trial","volume":"52","author":"Hoshino","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2025.123661_bb0080","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S1474-4422(14)70026-2","article-title":"Stroke and cerebrovascular diseases in patients with chronic kidney disease","volume":"13","author":"Toyoda","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2025.123661_bb0085","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrneph.2015.131","article-title":"Kidney-brain crosstalk in the acute and chronic setting","volume":"11","author":"Lu","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jns.2025.123661_bb0090","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","article-title":"Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data","volume":"3","author":"Matsushita","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.jns.2025.123661_bb0095","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/S0140-6736(21)01063-1","article-title":"Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective randoimsed, open-label, multicentre trial","volume":"397","author":"Koo","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2025.123661_bb0100","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1055\/a-1853-2952","article-title":"Clopidogrel monotherapy versus aspirin monotherapy in patients with established cardiovascular disease: systematic review and meta-analysis","volume":"122","author":"Tasoudis","year":"2022","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jns.2025.123661_bb0105","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.lfs.2008.09.027","article-title":"Intervention with cilostazol attenuates renal inflammation in streptozotocin-induced diabetic rats","volume":"83","author":"Wang","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.jns.2025.123661_bb0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11096-017-0578-4","article-title":"Effects of cilostazol and renin-angiotensin system (RAS) blockers on the renal disease progression of Korean patients: a retrospective cohort study","volume":"40","author":"Noh","year":"2018","journal-title":"Int. J. Clin. Pharmacol."},{"key":"10.1016\/j.jns.2025.123661_bb0115","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/STROKEAHA.122.039900","article-title":"Dual antiplatelet therapy with cilostazol for secondary prevention in lacunar stroke: subanalysis of the CSPS.com trial","volume":"54","author":"Nishiyama","year":"2023","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2025.123661_bb0120","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/17474930221112343","article-title":"Dual antiplatelet therapy with cilostazol in stroke patients with extracranial arterial stenosis or without arterial stenosis: a subgroup analysis of the CSPS.com trial","volume":"18","author":"Uchiyama","year":"2023","journal-title":"Int. J. Stroke"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25002813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25002813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:30:12Z","timestamp":1779769812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X25002813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":24,"alternative-id":["S0022510X25002813"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.123661","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of renal function on dual antiplatelet therapy using cilostazol for stroke prevention: a CSPS.com trial post hoc analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.123661","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123661"}}